Deutsche medizinische Wochenschrift (1946)最新文献

筛选
英文 中文
[Update on vaccination for older adults]. [老年人接种疫苗的最新情况]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2755-4911
Anja Kwetkat, Anne-Sophie Endres, Hans Jürgen Heppner
{"title":"[Update on vaccination for older adults].","authors":"Anja Kwetkat, Anne-Sophie Endres, Hans Jürgen Heppner","doi":"10.1055/a-2755-4911","DOIUrl":"https://doi.org/10.1055/a-2755-4911","url":null,"abstract":"<p><strong>Abstract: </strong>Older adults are highly susceptible to infections, some of which are vaccine preventable. Therefore, the Standing Committee on Vaccination (STIKO) regularly updates its vaccination recommendations for older adults as well. Since the 2025/26 season, the adjuvanted influenza vaccine is recommended for people aged 60 and older, in addition to the high-dose influenza vaccine. In addition, a one-time vaccination against respiratory syncytial virus in autumn has been added as a routine vaccination for 75-year-olds and as an indication-based vaccination for those aged 60 and older with severe underlying medical conditions. Little attention has been paid so far to the now well documented additional benefits of vaccinations against shingles, pneumococcal disease, influenza, and RSV - that is, effects that go beyond the primary therapeutic benefit and make a significant contribution to healthy aging. These include a reduction in myocardial and cerebrovascular events, as well as a protective effect against neurodegenerative processes. In particular it has been demonstrated that the influenza vaccine is as effective as statins in the secondary prevention of myocardial infarction. These findings could lead to an increased acceptance of vaccination and, consequently, to an increase in vaccination rates, which remain insufficient. To continue improving the benefits of vaccination in the future, vaccines need to be further developed to achieve greater efficacy, which could also help increase acceptance of vaccination. Several new developments are currently in the pipeline, particularly for the pneumococcal vaccine. Since March 2025, a 21-valent pneumococcal conjugate vaccine for adults has been licensed in Europe, specifically targeting the serotypes that cause IPD in adults. Additional pneumococcal vaccine candidates covering up to 31 serotypes are currently in development using new technologies and are undergoing Phase 2 or 3 trials.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1219-1224"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sleep reimagined: Current developments in sleep medicine for everyday medical practice]. [睡眠重新想象:睡眠医学在日常医疗实践中的最新发展]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2679-4851
Christoph Schöbel
{"title":"[Sleep reimagined: Current developments in sleep medicine for everyday medical practice].","authors":"Christoph Schöbel","doi":"10.1055/a-2679-4851","DOIUrl":"https://doi.org/10.1055/a-2679-4851","url":null,"abstract":"<p><strong>Abstract: </strong>Sleep disorders are among the most common complaints in medical practice. Regardless of their field of expertise and level of care, patients report non-restorative sleep, difficulty falling asleep or staying asleep, daytime fatigue or concentration problems. Nevertheless, sleep problems are often only casually recorded in everyday clinical practice or interpreted as a concomitant symptom of other diseases. Sleep is not a non-specific characteristic of well-being, but an actively regulated biological functional state with high clinical significance.Sleep influences central bodily functions such as cardiovascular regulation, metabolism, immune response and neural processing. Changes in these systems almost always affect sleep. Conversely, persistent sleep disorders can contribute to the manifestation or progression of chronic diseases. This results in a paradigm shift in medical practice: sleep should not only be addressed when symptoms are pronounced but should be understood as a regular component of the medical history.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1239-1246"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Venous thrombosis at unusual sites]. [不寻常部位静脉血栓形成]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2812-2179
Moritz Meusel, Henry Nording, Oliver Müller
{"title":"[Venous thrombosis at unusual sites].","authors":"Moritz Meusel, Henry Nording, Oliver Müller","doi":"10.1055/a-2812-2179","DOIUrl":"https://doi.org/10.1055/a-2812-2179","url":null,"abstract":"<p><strong>Abstract: </strong>Venous thrombosis at unusual sites such as the upper extremity, the splanchnic and cerebral veins, and rarer ovarian, renal and retinal sites has long been managed in analogy to lower-limb deep vein thrombosis because dedicated trials were lacking. This has changed substantially. The 2023 German S2k guideline now addresses these sites explicitly, and a growing body of randomized and prospective evidence supports the use of direct oral anticoagulants (DOACs). For upper-extremity thrombosis, therapeutic anticoagulation is first-line and is managed according to deep vein thrombosis. A functioning, still-needed catheter can remain in situ. For splanchnic vein thrombosis, anticoagulation reduces recurrence and mortality and improves recanalization, including in cirrhotic portal vein thrombosis (Child-Pugh A/B). In cirrhotic portal vein thrombosis DOACs are possible depending on the liver function (rivaroxaban/edoxaban in Child A, apixaban in Child B, low molecular weight heparin in Child C). A JAK2-V617F screen identifies an underlying myeloproliferative neoplasm before blood-count changes appear and should be part of the etiological work-up of a non-cirrhotic splanchnic vein thrombosis. For cerebral venous thrombosis, DOACs have shown to be as effective as vitamin K antagonists with fewer major, particularly intracranial, bleeds, while vaccine-induced immune thrombotic thrombocytopenia (VITT) requires non-heparin anticoagulation. For ovarian, renal and retinal veins, robust data remains absent. This article summarizes the practice-relevant advances for the general internist, focusing on the upper extremity and the splanchnic veins.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1207-1212"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[48-year-old female patient with diabetic ketoacidosis and an abnormal finding in the left breast]. [48岁女性糖尿病酮症酸中毒左乳异常]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2936-1378
Karsten Müssig, Ronald Lützenberg, Otfried Sauer, Thorsten Heilmann
{"title":"[48-year-old female patient with diabetic ketoacidosis and an abnormal finding in the left breast].","authors":"Karsten Müssig, Ronald Lützenberg, Otfried Sauer, Thorsten Heilmann","doi":"10.1055/a-2936-1378","DOIUrl":"https://doi.org/10.1055/a-2936-1378","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1205-1206"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sequential Oral Therapy for Endocarditis: Current Evidence and Clinical Practice]. 序贯口服治疗心内膜炎:目前的证据和临床实践。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2707-1092
Johannes Camp, Philipp Mathé, Marie Leibenguth, Siegbert Rieg
{"title":"[Sequential Oral Therapy for Endocarditis: Current Evidence and Clinical Practice].","authors":"Johannes Camp, Philipp Mathé, Marie Leibenguth, Siegbert Rieg","doi":"10.1055/a-2707-1092","DOIUrl":"https://doi.org/10.1055/a-2707-1092","url":null,"abstract":"<p><strong>Abstract: </strong>For decades, prolonged intravenous antibiotic therapy has been the standard of care for infective endocarditis. In light of recent evidence, this paradigm can no longer be upheld. The POET trial demonstrated that in selected patients with left-sided infective endocarditis partial oral antibiotic therapy is non-inferior to continued intravenous treatment and can be applied safely in the long term. This strategy is further supported by pharmacokinetic analyses, subgroup studies, and data from Denmark, Germany, and the United States, extending its validity beyond controlled trial settings. In clinical practice, however, implementation remains cautious, largely due to persistent uncertainties regarding patient selection, the optimal timing of oral switch, and appropriate oral regimens. This article summarizes the current evidence, discusses opportunities and limitations, and provides practical guidance on the key questions of oral therapy in infective endocarditis: who, when, and how.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1225-1232"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutic Endoscopic Ultrasound (EUS) - From Diagnostic Tool to Central Pillar in the Malignant (Palliative) Setting]. [治疗性超声内镜(EUS) -从诊断工具到恶性(姑息)环境的中心支柱]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2838-2071
Armin Kuellmer
{"title":"[Therapeutic Endoscopic Ultrasound (EUS) - From Diagnostic Tool to Central Pillar in the Malignant (Palliative) Setting].","authors":"Armin Kuellmer","doi":"10.1055/a-2838-2071","DOIUrl":"https://doi.org/10.1055/a-2838-2071","url":null,"abstract":"<p><p>Endoscopic biliary drainage remains the standard treatment for malignant biliary obstruction, with metal stent placement used for distal strictures. Percutaneous transhepatic cholangiodrainage (PTCD) has traditionally served as the rescue procedure following failed ERCP, though it typically requires multiple interventions to establish adequate drainage and often results in a permanent external catheter. EUS-guided biliary drainage (EUS-BD) has emerged as an alternative to PTCD in this setting. Comparative studies demonstrate that EUS-BD achieves comparable technical and clinical success to PTCD while showing lower rates of adverse events and reinterventions, supporting its consideration as a standard rescue option after unsuccessful ERCP.</p><p><p>A parallel paradigm shift is occurring in the management of malignant gastric outlet obstruction. Surgical gastroenterostomy has long been considered the gold standard, with duodenal stenting serving as an endoscopic alternative for patients unfit for surgery, albeit with frequently limited durability of symptom control. EUS-guided gastroenterostomy (EUS-GE) has shown lower reintervention rates than duodenal stenting in randomized controlled trials. More recently, RCTs have demonstrated that EUS-GE offers efficacy comparable to, and in some outcomes superior to, surgical gastroenterostomy, with at least non-inferior results on longer-term follow-up.</p><p><p>Together, these findings position EUS-guided techniques as increasingly favorable options over conventional percutaneous and surgical approaches for malignant biliary and gastric outlet obstruction, warranting broader incorporation into standard treatment algorithms.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1213-1218"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Systemic lupus erythematosus: new treatment targets and agents]. 系统性红斑狼疮:新的治疗靶点和药物。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2831-8077
Peter Korsten
{"title":"[Systemic lupus erythematosus: new treatment targets and agents].","authors":"Peter Korsten","doi":"10.1055/a-2831-8077","DOIUrl":"https://doi.org/10.1055/a-2831-8077","url":null,"abstract":"<p><strong>Abstract: </strong>Management of systemic lupus erythematosus (SLE) has moved towards a defined treat-to-target approach. In April 2025 the first German S3 guideline was published, complementing the 2023 EULAR recommendations and the 2025 EULAR update on kidney involvement. All emphasize hydroxychloroquine as a backbone, a prednisolone target of ≤5mg/day and early use of belimumab or anifrolumab without any specific preference. Two validated targets guide therapy: DORIS remission (clinical SLEDAI 0, PGA <0,5, prednisolone ≤5mg/day) and LLDAS (SLEDAI-2K ≤4 without vital organ activity, PGA ≤1, prednisolone ≤7,5mg/day). Anifrolumab has been approved for subcutaneous self-administration in the EU since December 2025. Obinutuzumab, a type II anti-CD20 antibody, met its primary endpoint in the phase III trials REGENCY and ALLEGORY. Dapirolizumab pegol enabled glucocorticoid tapering alongside BICLA response in a phase III trial. Cellular approaches are advancing: autologous CD19 CAR T cells led to long-lasting remission in the refractory SLE patients, while off-the-shelf allogeneic constructs and T-cell engagers such as teclistamab or blinatumumab are in early clinical development.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1247-1251"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Emergencies during heat-related extreme weather events]. [与高温有关的极端天气事件中的紧急情况]。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-11-01 Epub Date: 2026-11-02 DOI: 10.1055/a-2677-9690
Rosa van de Loo, Dirk Weismann
{"title":"[Emergencies during heat-related extreme weather events].","authors":"Rosa van de Loo, Dirk Weismann","doi":"10.1055/a-2677-9690","DOIUrl":"https://doi.org/10.1055/a-2677-9690","url":null,"abstract":"<p><strong>Abstract: </strong>Climate change is placing an increasing burden on emergency medical care. In addition to heat-related illnesses, exacerbations of common chronic diseases and a higher incidence of injuries are major contributors to the growing number of emergency department presentations. At the same time, vector-borne diseases and other climate-related health risks are becoming increasingly relevant. Against the backdrop of demographic change, strengthening societal resilience, improving public health literacy, and implementing effective heat protection measures are of particular importance. In addition to prevention and public education, regular review of heat-sensitive medications should be considered an essential component of patient care. Overall, the health consequences of climate change are emerging as a major challenge for both prehospital and hospital emergency care, underscoring the need for timely adaptation of healthcare systems and emergency care strategies.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 22","pages":"1233-1238"},"PeriodicalIF":0.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
["Standard Operating Procedure" (SOP) - Pain Therapy in Various Tumor Constellations]. “标准操作程序”(SOP) -不同肿瘤类型的疼痛治疗”。
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-10-01 Epub Date: 2026-10-05 DOI: 10.1055/a-2911-5864
Michael Brinkers, Giselher Pfau, Jana Bergner, Frank Meyer
{"title":"[\"Standard Operating Procedure\" (SOP) - Pain Therapy in Various Tumor Constellations].","authors":"Michael Brinkers, Giselher Pfau, Jana Bergner, Frank Meyer","doi":"10.1055/a-2911-5864","DOIUrl":"https://doi.org/10.1055/a-2911-5864","url":null,"abstract":"<p><strong>Background: </strong>Pain therapy has obtained a high importance in clinical practice in the meantime and has become indispensable, in particular, with regard to a sufficient perioperative/-interventional case management but also related to a certain approach, specific (problematic) diagnoses, syndromes and special symptomatologies.</p><p><strong>Aim: </strong>To provide a prompt and standardized access to a competently developed compact \"Standard Operating Procedure\" (SOP) on interdisciplinary pain therapy in tumor patients with a broad profile of (possible) diagnoses at a subspecialized medical center based on i) experiences from long-term clinical practice and ii) current references from the scientific medical literature (not to substitute completely earlier publications and text books).</p><p><strong>Method: </strong>Narrative short overview on the \"SOP - Pain Therapy in tumor diseases/patients\" (provided as QR code at the end).</p><p><strong>Results (corner points): </strong>In case of tumor-associated pain, opioids represent the primarily considered group of drugs for an efficient medication. Medication with opioids is limited by hepatic and renal insufficiency, type of opioid (e.g., Tapentadol's effect is not sufficient), further contraindications (e.g., MST in chronic obstructive pulmonary disease [COPD]) and mode of possible drug administration (patients cannot swallow or in lack of consciousness). In patients with tumor-associated pain, it needs to be asked for anxiety.</p><p><strong>Discussion: </strong>A couple of years ago, the interdisciplinary working group at the University Hospital of Magdeburg (Germany) created and established SOP's for postoperative pain therapy in general and abdominal surgery followed by vasculary surgery/medicine in 2024.</p><p><strong>Conclusion: </strong>Tumor-associated pain belongs to the type of pain (in addition to birth pang and postoperative pain), which can be approached best. This represents a call to action. It comprises consequent, adequate drug administration with sufficient dosage according to the WHO scheme (WHO I actually not necessary), psychotropics and drug-free procedures.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 20","pages":"1132-1144"},"PeriodicalIF":0.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149120737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tricuspid Valve Disease - Evaluation and Management in Clinical Practice]. 三尖瓣疾病的临床评价与处理
IF 0.7
Deutsche medizinische Wochenschrift (1946) Pub Date : 2026-10-01 Epub Date: 2026-10-05 DOI: 10.1055/a-2794-8087
Philipp von Stein, Stephan Baldus
{"title":"[Tricuspid Valve Disease - Evaluation and Management in Clinical Practice].","authors":"Philipp von Stein, Stephan Baldus","doi":"10.1055/a-2794-8087","DOIUrl":"https://doi.org/10.1055/a-2794-8087","url":null,"abstract":"<p><strong>Abstract: </strong>Tricuspid valve disease encompasses a spectrum of conditions, among which tricuspid regurgitation is the most prevalent and clinically significant. Affected patients are typically elderly and present with systemic congestion, impaired renal and hepatic function, and reduced quality of life. Echocardiography enables mechanistic classification, severity grading, and assessment of right ventricular function. While medical therapy remains foundational, transcatheter interventions - including edge-to-edge repair and valve replacement - have emerged as options for high-risk patients. Randomized trials demonstrate improvements in symptoms and quality of life, with emerging evidence for reductions in heart failure hospitalizations. This article provides a practice-oriented overview of diagnosis, management, and referral pathways for tricuspid valve disease, including rarer entities such as tricuspid stenosis, endocarditis, and carcinoid heart disease.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"151 20","pages":"1119-1125"},"PeriodicalIF":0.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149120755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书